Ignore Facebook posts advertising a cure for stroke, arthritis, hypertension and other illnesses. IN SHORT: Several Facebook posts claim that these "anti-stroke herbal capsules" c ...

Johnson & Johnson (NYSE:JNJ) reported its third-quarter 2024 earnings, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $2.04, slightly above the forecasted $2.02. The ...